Maximum quantity allowed is 999
Please select the quantity
CAS RN: 13292-46-1 | Product Number: R0079
Rifampicin
×
![]()
×
Purity: >98.0%(T)
Synonyms:
- Rifampin
- Rifamycin AMP
Product Documents:
| Size | Unit Price | Shanghai | Tianjin | Japan* |
|---|---|---|---|---|
| 1G |
¥105.00
|
32 | 1 | Contact Us |
| 5G |
¥330.00
|
≥40 | 5 | ≥100 |
| 25G |
¥970.00
|
≥40 | 1 | ≥100 |
* For order or inquiry, please contact
Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
| Product Number | R0079 |
| Purity / Analysis Method | >98.0%(T) |
| Molecular Formula / Molecular Weight | C__4__3H__5__8N__4O__1__2 = 822.95 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Light Sensitive,Moisture Sensitive,Heat Sensitive |
| Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 13292-46-1 |
| Reaxys Registry Number | 5723476 |
| PubChem Substance ID | 87560354 |
| Merck Index (14) | 8216 |
| MDL Number | MFCD00151389 |
Specifications
| Appearance | Orange to Amber to Dark red powder to crystal |
| Purity(HPLC) | min. 94.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 188 °C(dec.) |
| Solubility (soluble in) | Dimethylformamide |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| RTECS# | VJ7000000 |
Transport Information:
| Customs Control Conditions (Q) | Q类 （糖类，生物碱类，抗生素类，激素类） |
Application
Rifampicin: A Rifamycin Antibiotic with Activity against a Wide Variety of Organisms including Tuberculosis Germs
Rifampicin (other name: rifampin) is a semisynthetic rifamycin antibiotic, which is chemically synthesized from rifamycin, which is isolated from a strain of the actinomycete Amycolatopsis mediterranei. Rifampicin has activity against a wide variety of organisms, including tuberculosis germs and Staphylococcus aureus, as well as in vitro activity against penicillin-resistant Streptococcus pneumoniae, and many Gram-negative bacteria. Rifampicin inhibits bacterial DNA-dependent RNA synthesis by inhibiting bacterial DNA-dependent RNA polymerase, which is responsible for DNA transcription. In contrast, the corresponding mammalian enzymes are not affected by rifampicin. Bacterial resistance to rifampicin is caused by mutations leading to a change in the structure of the β subunit of RNA polymerase. Rifampicin acts as a cytochrome P450 3A4 (CYP3A4) inducer, which increase the activity of CYP3A4. Thus, rifampicin can cause drug interaction with other medications.
References
- Rifampin: A Semisynthetic derivative of rifamycin. Prototype for the future (a review)
- Rifampin, a useful drug for nonmycobacterial infections (a review)
- Rifampin: mechanisms of action and resistance
- Pharmacokinetic interactions with rifampicin: Clinical relevance
- Rifampin and rifabutin drug interactions. An update
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.